Welcome to Pegasus Capital

Pegasus Capital is a dynamic and independent corporate finance firm focused on providing high-quality financial advice to growth-oriented Irish companies.   In today’s uncertain environment, where execution risk is high and it takes longer to get deals completed, Pegasus Capital goes the extra mile for our clients to ensure that their objectives are met

About Pegasus Capital

Pegasus Capital is led by a team of highly qualified financial advisory and private equity professionals.  Our team has a strong reputation for high quality strategic and financial advice, for providing indepth market analysis to our clients, and for identifying attractive investment opportunities

We work closely with leading entrepreneurs, growth-oriented private companies and financial investors and we operate across a range of industry sectors with a particular focus on the technology, lifesciences and manufacturing sectors

  • For early-stage technology and lifesciences companies seeking to raise equity funding; we have excellent knowledge of current market trends and unrivalled relationships with the most active players in the European venture capital community
  • For more developed companies seeking to raise capital; we have extensive private equity relationships with funds seeking to finance development capital, buy-out or recapitalisation opportunities
  • In an exit scenario, we believe that shareholder value is more often maximised once a company has received an approach, rather than by formally putting the company up for sale.   On that basis, we work closely with exit-minded companies to get them ‘on the radar’ of potential acquirers well in advance of any desired liquidity event

Senior Team

Pegasus Capital is led by a high-energy and experienced team who are dedicated to providing our client companies with advice of the highest quality.   Our senior team has more than 50 years combined operating, strategic and financial markets experience


Our Services

Pegasus Capital is primarily focused on advising companies on the following matters:

  • Raising series A, B or later stage venture capital funding from European funds
  • Raising private equity funding by way of buy-out or development capital funding
  • Advice in relation to corporate acquisitions, mergers and joint ventures
  • Advice on trade sales with a view to maximising shareholder value, sometimes with US-based co-advisers with whom Pegasus Capital has pre-existing relationships
  • Advice in relation to management buy-out (‘MBO’) and management buy-in (‘MBI’) transactions
  • Independent advice for companies seeking to raise bank debt
  • Market analysis & strategic reviews
  • Corporate and investment planning
  • Valuation opinions

Recent Experience

Not Disclosed
Equity fundraising for Wavebreak Media Ltd.
Not Disclosed
Sale of Oxford Biosystems Ltd. to BioVendor Ltd.
USD 150,000,000
Sale of GenCell BioSystems Ltd. to Becton, Dickinson & Co.
Not Disclosed
Sale of Cappella Peel Away Inc. to Stentys SA
EUR 23,400,000
Sale of Aran Candy Ltd. to Cloetta AB
EUR 3,000,000
Seed fundraising for Embo Medical Ltd.
Not Disclosed
Management Buy-In of Aalto Bio Reagents Ltd.
Not Disclosed
Acquisition of Independent Colleges by the Barry family
USD 1,000,000
Seed fundraising for VideoElephant Ltd.
Not Disclosed
Sale of Lotus FM Ltd. to Aramark Ireland Holdings Ltd.
USD 5,000,000
Series A fundraising for GenCell BioSystems Ltd.
Not Disclosed
Seed fundraising for Poly Pico Technologies Ltd.
USD 1,000,000
Series A fundraising for adforce.com
USD 9,000,000
Series A fundraising for FeedHenry Ltd. led by Intel Corp.
EUR 4,000,000
Series A fundraising for Cleverbug Ltd.
STG 75,000,000
Sale of Maya Hyde Park Ltd. and Dorset West Ltd.

Contact Us

Pegasus Capital

No. 9 Upper Pembroke St.
Dublin 2

+353 1 9053502